Literature DB >> 33984476

Small molecule approaches to treat autoimmune and inflammatory diseases (Part II): Nucleic acid sensing antagonists and inhibitors.

Xiaoqing Wang1, Yafei Liu1, Xingchun Han1, Ge Zou1, Wei Zhu1, Hong Shen1, Haixia Liu2.   

Abstract

Nucleic acid sensing pathways play an important role in the innate immune system, protecting hosts against infections. However, a large body of evidence supports a close association between aberrant activation of those pathways and autoimmune and inflammatory diseases. Part II of the digest series on small molecule approaches to autoimmune and inflammatory diseases concentrates on recent advances with respect to small molecule antagonists or inhibitors of the nucleic acid sensing pathways, including endosomal TLRs, NLRP3 inflammasome and cGAS-STING.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoimmune and inflammatory diseases; Inhibitors; Innate immunity; Nucleic acid; Small molecule antagonists

Mesh:

Substances:

Year:  2021        PMID: 33984476     DOI: 10.1016/j.bmcl.2021.128101

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Novel Carbazoles for Treating Inflammatory and Autoimmune Diseases.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-07-21       Impact factor: 4.632

2.  Spiro(isobenzofuranazetidine) Compounds for Treating Autoimmune Diseases.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-08-17       Impact factor: 4.632

3.  Structure-Based Optimization of a Fragment-like TLR8 Binding Screening Hit to an In Vivo Efficacious TLR7/8 Antagonist.

Authors:  Claudia Betschart; Michael Faller; Florence Zink; René Hemmig; Jutta Blank; Eric Vangrevelinghe; Marjorie Bourrel; Ralf Glatthar; Dirk Behnke; Kerstin Barker; Andreas Heizmann; Daniela Angst; Pierre Nimsgern; Sébastien Jacquier; Tobias Junt; Géraldine Zipfel; Giulia Ruzzante; Pius Loetscher; Sarah Limonta; Stuart Hawtin; Cedric Bernard Andre; Thomas Boulay; Roland Feifel; Thomas Knoepfel
Journal:  ACS Med Chem Lett       Date:  2022-03-10       Impact factor: 4.632

4.  Novel Triazatricycle Compounds for Treating Autoimmune Diseases.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-06-25       Impact factor: 4.632

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.